StockWatch
·

SAMRAT PHARMACHEM LTD.-$ Q4 FY25 Results

SAMRATPHQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue71.2011.8%
Total Income71.1011.7%
Expenditure71.4619.6%
PBT-0.36109.3%
Net Profit-0.40114.3%
OPM0.18%5.55pp
NPM-0.56%4.93pp
EPS1.2985.7%
View full financials

Informational and educational content only. Not investment advice.